You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK):蘇州基金及天津基金已分別於中國證券投資基金業協會完成備案
格隆匯 12-30 17:32

格隆匯 12 月 30日丨復星醫藥(02196.HK)公佈,2020年5月18日,公司控股子公司/企業寧波復瀛、蘇州星晨與關聯方復星高科技以及其他6方投資人簽訂《蘇州基金合夥合同》,以共同出資設立蘇州基金;蘇州基金計劃募集資金人民幣10億元,其中首輪計劃募集資金人民幣8.53億元。同日,公司控股子公司/企業寧波復瀛、天津星耀、天津星海與關聯方復星高科技以及其他2方投資人簽訂《天津基金合夥合同》等,以共同出資設立天津基金,天津基金計劃募集資金人民幣5億元。

蘇州基金、天津基金為平行基金,並共同組成復健一期基金。該等平行基金將在同時滿足各自決策機制約定的條件下共同實施對外投資,平行基金在同一具體項目中的投資比例分配將按屆時各自在復健一期基金中的相對認繳比例確定。

蘇州基金、天津基金設立已經公司第八屆董事會第十六次會議(臨時會議)審議通過;截至公吿日,蘇州基金已完成首輪募集(募集金額約人民幣85,294萬元)、天津基金已募集完成並封閉,上述基金已分別於中國證券投資基金業協會完成備案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account